<DOC>
	<DOCNO>NCT01732341</DOCNO>
	<brief_summary>This study test compare Stentys Stent Multi-Link Vision™ stent system ( Abbott Vascular Inc. ) patient heart attack . It expect Stentys stent bad Vision stent .</brief_summary>
	<brief_title>Stentys Coronary Stent System Clinical Trial Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description>Coronary artery disease continue common cause morbidity mortality occidental world . Treatment coronary atherosclerotic disease significantly advance interventional cardiology , particular advent coronary arterial stent . In comparison angioplasty alone , stent reduce incidence angiographic well clinical restenosis , recurrence angina , need coronary arterial bypass graft ( CABG ) surgery , need repeat revascularization occurrence major adverse cardiac event ( MACE ) .However , problem remain due failure achieve optimal stent apposition normal myocardial reperfusion . Early stent malapposition may due incomplete expansion undersizing balloon-expandable stent . Several study emphasize importance early malapposition set ST elevation MI , substantial thrombotic burden presence diffuse vasoconstriction may contributory . The Stentys Coronary Stent System include self-expanding bare metal ( nitinol ) stent rapid exchange ( RX ) delivery system . In view theoretical implication malapposition , self-expanding property may offer potential benefit . This study design evaluate safety effectiveness Stentys Coronary Stent System treatment de novo stenotic lesion coronary artery patient undergo primary revascularization due AMI compare Multi-Link Vision™ coronary stent system ( Abbott Vascular Inc . The study power non-inferiority Stentys Coronary Stent System compare Vision Stent System .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>General Inclusion Criteria 1 . Subject ≥ 18 year old . 2 . Subject experience clinical symptom consistent AMI &gt; 30 min . duration . 3 . ST elevation ≥1 mm ≥2 contiguous lead new left bundle branch block , true posterior MI ST depression ≥1 mm ≥2 contiguous anterior lead . 4 . Symptom duration &lt; 12 hour prior sign inform consent . 5 . Subject catheterization laboratory procedure start within 2 hour consent . 6 . Patient provide write informed consent . 7 . Patient agrees require followup procedure visit . Angiographic Inclusion Criteria 1 . Based coronary anatomy , PCI indicate culprit lesion anticipate use stenting . 2 . The vessel diameter either know expect 2.54.0mm , without excessive tortuosity diffuse distal disease . 3 . Lesion length ≥12mm ≤ 23mm General Exclusion Criteria 1 . Currently enrol another investigational device drug trial complete primary endpoint clinically interfere current study endpoint . 2 . A previous coronary interventional procedure kind within 30 day prior procedure . 3 . Female patient childbearing potential know pregnant . 4 . Patients undergo cardiopulmonary resuscitation . 5 . Cardiogenic shock ( SBP &lt; 80 mmHg &gt; 30 minute , require IV pressor emergency IABP hypotension ) . 6 . The subject require multivessel PCI time index procedure stag procedure target vessel within 9 month nontarget vessel within 30 day postprocedure . 7 . The target lesion require treatment device PTCA prior stent placement ( , limit , directional coronary atherectomy , excimer laser , rotational atherectomy , etc. ) . Thrombus aspiration may use per operator discretion . 8 . Attempted thrombolysis . 9 . Comorbid condition ( ) could limit subject 's ability participate trial comply followup requirement , impact scientific integrity trial . 10 . Concurrent medical condition life expectancy le 12 month . 11 . Known leave ventricular ejection fraction ( LVEF ) &lt; 25 % recent evaluation ( prior index hospitalization ) . 12 . History cerebrovascular accident transient ischemic attack last 6 month . 13 . Active peptic ulcer active gastrointestinal ( GI ) bleeding . 14 . History bleed diathesis coagulopathy inability accept blood transfusion . 15 . Known hypersensitivity contraindication aspirin , heparin bivalirudin , clopidogrel ticlopidine , cobalt , nickel , sensitivity contrast medium , adequately premedicated . 16 . Known serum creatinine level &gt; 2.5 mg/dl , eGFR &lt; 30 , hemodialysis dependent . Angiographic Exclusion Criteria 1 . Unprotected leave main coronary artery disease ( obstruction great 60 % leave main coronary artery protect least one nonobstructed bypass graft leave anterior descending ( LAD ) leave circumflex ( LCX ) artery branch thereof ) . 2 . Multivessel intervention require index procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>STEMI</keyword>
	<keyword>BMS</keyword>
	<keyword>Self-expanding stent</keyword>
</DOC>